FDA Warns Ebola Treatments for Sale are Fake
The U.S. FDA is advising consumers to be aware of products sold online claiming to prevent or treat the Ebola virus -- a scam that has gained momentum since the outbreak of the Ebola virus in West Africa.
Apotex Loses NAFTA Dispute with FDA
Apotex Inc. announced that a arbitration tribunal constituted under Chapter Eleven of the North American Free Trade Agreement has rejected the company's claims that the FDA violated NAFTA by prohibiting imports of Apotex products from two plants in Ontario, Canada.
India Issues New GMP-Inspection Rules
India’s Central Drugs Standard Control Organization (CDSCO) has issued new guidelines for state inspectors on how to prepare for and conduct GMP inspections of drug manufacturing facilities.
Boehringer Ingelheim to BMJ: Your Pradaxa Allegations are Old News
A recent article published in the British Medical Journal asserts that Boehringer Ingelheim withheld from regulators important analyses regarding how to use its blockbuster anticoagulant stroke drug as safely and effectively as possible; Boehringer Ingelheim strongly objects.